These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11390628)

  • 41. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX; Srinivasan N; Ren EE; Chan SH
    Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
    Gutsch DE; Marcu KB; Kenney SC
    Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
    Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
    J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.
    Bhende PM; Dickerson SJ; Sun X; Feng WH; Kenney SC
    J Virol; 2007 Jul; 81(14):7363-70. PubMed ID: 17494074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
    Zalani S; Holley-Guthrie E; Kenney S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9194-9. PubMed ID: 8799177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus.
    Chang PJ; Chang YS; Liu ST
    J Virol; 1998 Jun; 72(6):5128-36. PubMed ID: 9573284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
    J Virol; 2005 Jun; 79(12):7338-48. PubMed ID: 15919888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.
    Zalani S; Coppage A; Holley-Guthrie E; Kenney S
    J Virol; 1997 Apr; 71(4):3268-74. PubMed ID: 9060693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription.
    Hwang S; Gwack Y; Byun H; Lim C; Choe J
    J Virol; 2001 Oct; 75(19):9509-16. PubMed ID: 11533213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site.
    Glaser G; Vogel M; Wolf H; Niller HH
    Arch Virol; 1998; 143(10):1967-83. PubMed ID: 9856084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A study of Epstein-Barr virus BRLF1 activity in a Drosophila model system.
    Adamson A; LaJeunesse D
    ScientificWorldJournal; 2012; 2012():347597. PubMed ID: 22629134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.
    Bentz GL; Liu R; Hahn AM; Shackelford J; Pagano JS
    Virology; 2010 Jun; 402(1):121-8. PubMed ID: 20381110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.
    Ruvolo V; Wang E; Boyle S; Swaminathan S
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8852-7. PubMed ID: 9671768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein.
    Han Z; Verma D; Hilscher C; Dittmer DP; Swaminathan S
    J Virol; 2009 Nov; 83(22):11635-44. PubMed ID: 19726500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R trans activator.
    Nicholas J; Coles LS; Newman C; Honess RW
    J Virol; 1991 May; 65(5):2457-66. PubMed ID: 1850023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production.
    Ruvolo V; Sun L; Howard K; Sung S; Delecluse HJ; Hammerschmidt W; Swaminathan S
    J Virol; 2004 Jan; 78(1):340-52. PubMed ID: 14671116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.